Wenn die zweite Zyklushälfte alles verändert: Die Lutealphase bei ADHS

Autor:innen

• 

  Caroline Kloss

  klinischer Psychologin (M.Sc.)

Quellen

1. Broughton, T., Lambert, E., Wertz, J., & Agnew-Blais, J. (2025). Increased risk of provisional premenstrual dysphoric disorder (PMDD) among females with attention-deficit hyperactivity disorder (ADHD): Cross-sectional survey study. British Journal of Psychiatry, 226(6), 410–417.
2. de Jong, M., Wynchank, D.S.M.R., van Andel, E., Beekman, A.T.F., & Kooij, J.J.S. (2023). Female-specific pharmacotherapy in ADHD: Premenstrual adjustment of psychostimulant dosage. Frontiers in Psychiatry, 14, 1306194.
3. Dorani, F., Bijlenga, D., Beekman, A.T.F., van Someren, E.J.W., & Kooij, J.J.S. (2021). Prevalence of hormone-related mood disorder symptoms in women with ADHD.
4. Eng, A.G., Nirjar, U., Elkins, A.R., Sizemore, Y.J., Monticello, K.N., Petersen, M.K., Miller, S.A., Barone, J., Eisenlohr-Moul, T.A., & Martel, M.M. (2024).
5. Lin, P.-C., Ko, C.-H., & Yen, J.-Y. (2022). Early and late luteal executive function, cognitive and somatic symptoms, and emotional regulation of women with premenstrual dysphoric disorder. Journal of Personalized Medicine, 12(5), 819.
6. Osianlis, E., Thomas, E.H.X., Jenkins, L.M., & Gurvich, C. (2025).
7. Wynchank, D., Sutrisno, R.M.G.T.M.F., van Andel, E., & Kooij, J.J.S. (2025). Menstrual cycle-related hormonal fluctuations in ADHD: Effect on cognitive functioning – A narrative review. Journal of Clinical Medicine, 15(1), 121.